AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 165 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $484,329 | +0.4% | 17,102 | -18.6% | 0.00% | 0.0% |
| Q1 2023 | $482,462 | -54.4% | 21,004 | -44.3% | 0.00% | -50.0% |
| Q4 2022 | $1,058,756 | -52.4% | 37,705 | -52.0% | 0.00% | -50.0% |
| Q3 2022 | $2,223,000 | -36.4% | 78,602 | -50.1% | 0.00% | +33.3% |
| Q2 2022 | $3,493,000 | +3.2% | 157,531 | +156.6% | 0.00% | 0.0% |
| Q2 2021 | $3,384,000 | +24.1% | 61,400 | +20.4% | 0.00% | 0.0% |
| Q2 2020 | $2,727,000 | +833.9% | 50,988 | +518.6% | 0.00% | – |
| Q1 2020 | $292,000 | +90.8% | 8,243 | +316.7% | 0.00% | – |
| Q3 2018 | $153,000 | -91.3% | 1,978 | -90.5% | 0.00% | -100.0% |
| Q2 2018 | $1,751,000 | -14.6% | 20,784 | -32.4% | 0.00% | -33.3% |
| Q3 2017 | $2,051,000 | – | 30,734 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |